Literature DB >> 30353794

The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA.

J L McLaren1, J D Lichtenstein2.   

Abstract

Children with intellectual and developmental disabilities (IDD) are likely to receive high-risk prescribing practices, such as polypharmacy, long-term use of psychotropic medications, and overuse of antipsychotics. Behavioural interventions, such as applied behavioural analysis, are evidence-based practices for children with IDD and should be the first-line treatment. Short-term use of psychotropic medications may be helpful in reducing the severity and frequency of challenging behaviours while evidence-based behavioural interventions are pursued. In this essay, we offer practical guidelines for better care.

Entities:  

Keywords:  Autism; child psychiatry; evidence-based psychiatry; psychotropic drugs

Mesh:

Substances:

Year:  2018        PMID: 30353794      PMCID: PMC6999033          DOI: 10.1017/S2045796018000604

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  20 in total

1.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

2.  Migrant children in US were given range of psychotropic drugs to control behaviour, lawsuits allege.

Authors:  Owen Dyer
Journal:  BMJ       Date:  2018-07-03

3.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  2005-11

4.  The prevalence of challenging behaviors: a total population study.

Authors:  E Emerson; C Kiernan; A Alborz; D Reeves; H Mason; R Swarbrick; L Mason; C Hatton
Journal:  Res Dev Disabil       Date:  2001 Jan-Feb

Review 5.  Evidence-Based Practices for Children, Youth, and Young Adults with Autism Spectrum Disorder: A Comprehensive Review.

Authors:  Connie Wong; Samuel L Odom; Kara A Hume; Ann W Cox; Angel Fettig; Suzanne Kucharczyk; Matthew E Brock; Joshua B Plavnick; Veronica P Fleury; Tia R Schultz
Journal:  J Autism Dev Disord       Date:  2015-07

Review 6.  The co-occurrence of mental disorders in children and adolescents with intellectual disability/intellectual developmental disorder.

Authors:  Kerim M Munir
Journal:  Curr Opin Psychiatry       Date:  2016-03       Impact factor: 4.741

7.  Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

Authors:  Bryan H King; Eric Hollander; Linmarie Sikich; James T McCracken; Lawrence Scahill; Joel D Bregman; Craig L Donnelly; Evdokia Anagnostou; Kimberly Dukes; Lisa Sullivan; Deborah Hirtz; Ann Wagner; Louise Ritz
Journal:  Arch Gen Psychiatry       Date:  2009-06

8.  Characteristics of Children Prescribed Antipsychotics: Analysis of Routinely Collected Data.

Authors:  Sinead Brophy; Jonathan Kennedy; Fabiola Fernandez-Gutierrez; Ann John; Robert Potter; Christine Linehan; Michael Kerr
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-02-27       Impact factor: 2.576

9.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

Review 10.  Aggression in autism spectrum disorder: presentation and treatment options.

Authors:  Sarah E Fitzpatrick; Laura Srivorakiat; Logan K Wink; Ernest V Pedapati; Craig A Erickson
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-23       Impact factor: 2.570

View more
  1 in total

1.  Inter-class Concomitant Pharmacotherapy in Medicaid-Insured Youth Receiving Psychiatric Residential Treatment.

Authors:  Gail A Edelsohn; Kemal Eren; Meghna Parthasarathy; Neal D Ryan; Amy Herschell
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.